FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Actavis Elizabeth Dextroamphetamine Saccharate Recall

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amp…

Actavis Elizabeth LLC · Elizabeth, NJ

Risk level
Class II
Reported by FDA
Apr 13, 2016
Recall ID
D-0814-2016
Check your lot numberHow we source this data

Summary

Actavis Elizabeth recalled Dextroamphetamine Saccharate starting Feb 16, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0814-2016 on Apr 13, 2016. Reason: Failed Impurities/Degradation Specifications: Out of specification for impurities. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification for impurities.

Product description

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 20 mg, 100 ct. bottle, Rx Only. Manufactured by: Actavis Elizabeth LLC, Elmora Avenue, Elizabeth, NJ 07207. Distributed by: Actavis, Inc., 80 Columbia Road, Bldg B, Morristown, NJ 07960. NDC: 45963-748-11.

Lot numbers, UPCs & expiration codes

Lot #: 3992J141, Expiry: 5/16; Lot #: 3993J142, Expiry: 5/16; Lot #: 0695B151, Expiry: 7/16; Lot #: 0696B151, Expiry: 7/16; Lot #: 0378A151, Expiry: 7/16; Lot #: 0379A151, Expiry: 7/16; Lot #: 0697B151, Expiry: 8/16; Lot #: 2427F151, Expiry: 11/16; Lot #: 1947E151, Expiry: 11/16; Lot #: 1330C151, Expiry: 11/16; Lot #: 1331C151, Expiry: 11/16; Lot #: 1946E151, Expiry: 11/16; Lot #: 3652H151, Expiry: 2/17; Lot #: 3653H151, Expiry: 3/17, Lot #: 3654H151, Expiry: 3/17; Lot #: 4251K151, Expiry: 3/17; Lot #: 4250K151, Expiry: 4/17; Lot #: 4252K151, Expiry: 4/17; Lot #: 4249K151, Expiry: 4/17; Lot #: 5101M151, Expiry: 5/17.

Where it was sold

US: Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0814-2016
Classification
Class II
Status
Terminated
Recall initiated
Feb 16, 2016
FDA report date
Apr 13, 2016
Quantity
257,746 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis Elizabeth LLC

Original FDA data

Every field from FDA enforcement report D-0814-2016, exactly as published.

Show all FDA fields
City
Elizabeth
State
NJ
Status
Terminated
Country
United States
Event ID
73474
Address
200 Elmora Ave
Code information
Lot #: 3992J141, Expiry: 5/16; Lot #: 3993J142, Expiry: 5/16; Lot #: 0695B151, Expiry: 7/16; Lot #: 0696B151, Expiry: 7/16; Lot #: 0378A151, Expiry: 7/16; Lot #: 0379A151, Expiry: 7/16; Lot #: 0697B151, Expiry: 8/16; Lot #: 2427F151, Expiry: 11/16; Lot #: 1947E151, Expiry: 11/16; Lot #: 1330C151, Expiry: 11/16; Lot #: 1331C151, Expiry: 11/16; Lot #: 1946E151, Expiry: 11/16; Lot #: 3652H151, Expiry: 2/17; Lot #: 3653H151, Expiry: 3/17, Lot #: 3654H151, Expiry: 3/17; Lot #: 4251K151, Expiry: 3/17; Lot #: 4250K151, Expiry: 4/17; Lot #: 4252K151, Expiry: 4/17; Lot #: 4249K151, Expiry: 4/17; Lot #: 5101M151, Expiry: 5/17.
Postal code
07202-1106
Report date
Apr 13, 2016
Product type
Drugs
Recall number
D-0814-2016
Classification
Class II
Recalling firm
Actavis Elizabeth LLC
Product quantity
257,746 Bottles
Termination date
Sep 22, 2017
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification for impurities.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 20 mg, 100 ct. bottle, Rx Only. Manufactured by: Actavis Elizabeth LLC, Elmora Avenue, Elizabeth, NJ 07207. Distributed by: Actavis, Inc., 80 Columbia Road, Bldg B, Morristown, NJ 07960. NDC: 45963-748-11.
Distribution pattern
US: Nationwide
Recall initiation date
Feb 16, 2016
Initial firm notification
Letter
Center classification date
Apr 7, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0814-2016, published Apr 13, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls